Flubrotizolam is a potent a highly active benzodiazepine compound. Developed for clinical purposes, flubrotizolam possesses remarkable sedative effects. Its chemical properties reveal a high affinity for the GABA receptor, resulting significant CNS depression. Despite its potential therapeutic applications, flubrotizolam's illicit use has increased